Science

Elvina Almuradova: A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer

Elvina Almuradova/LinkedIn

Feb 27, 2025, 09:08

Elvina Almuradova: A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer

Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an article by Hasan Cagri Yildirim, et al. on LinkedIn:

“Excited to share our latest publication: “A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications”.

Our review explores the prognostic and clinical significance of KRAS mutations in early-stage colorectal cancer (CRC), particularly in MSS tumors. Findings highlight the need for routine molecular profiling to refine risk stratification and guide adjuvant therapy decisions.

Read more.”

A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications.

Authors: Hasan Cagri Yildirim, et al.

Adjuvant Therapy cancer colorectal cancer CRC Elvina Almuradova European Institute of Oncology fight against cancer Global fight against cancer Hasan Cagri Yildirim IEO molecular profiling OncoDaily Oncology RAS mutations

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer